Largest pharmaceutical companies in the United States by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 44 pharmaceutical companies in the United States ranked by earnings, at PLN 108.4B, ahead of Eli Lilly (PLN 83.4B) and Merck & Co (PLN 73.8B). Figures as of 20 Nov 2026, 04:38 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- Johnson & JohnsonPLN 108.4B
- Median
- -PLN 193.1M
- Combined market value
- PLN 15.1T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | PLN 108.4B | PLN 2.6T | PLN 1,079.87 | 2.04% down | 34% up | ||
| 2 | Eli LillyLLY · Health Care | PLN 83.4B | PLN 4.86T | PLN 5,461.70 | 2.29% down | 33% up | ||
| 3 | Merck & CoMRK · Health Care | PLN 73.8B | PLN 1.32T | PLN 536.86 | 3.61% down | 45% up | ||
| 4 | PfizerPFE · Health Care | PLN 31.4B | PLN 634.5B | PLN 111.33 | 1.85% down | 15% up | ||
| 5 | Bristol-Myers SquibbBMY · Health Care | PLN 28.5B | PLN 482.1B | PLN 235.83 | 2.05% down | 30% up | ||
| 6 | Abbott LaboratoriesABT · Health Care | PLN 26.4B | PLN 727.2B | PLN 419.88 | 0.58% down | 16% down | ||
| 7 | Regeneron PharmaceuticalsREGN · Health Care | PLN 18.2B | PLN 386.1B | PLN 3,732.46 | 2.35% down | 28% up | ||
| 8 | AbbVieABBV · Health Care | PLN 17.1B | PLN 2.03T | PLN 1,146.17 | 0.86% down | 25% up | ||
| 9 | Vertex PharmaceuticalsVRTX · Health Care | PLN 16B | PLN 533.6B | PLN 2,104.69 | 2.94% down | 27% up | ||
| 10 | ZoetisZTS · Health Care | PLN 10.8B | PLN 132.7B | PLN 326.58 | 5.59% down | 26% down | ||
| 11 | United TherapeuticsUTHR · Health Care | PLN 5.4B | PLN 96.3B | PLN 2,260.08 | 3.16% down | 22% up | ||
| 12 | Royalty PharmaRPRX · Health Care | PLN 3.1B | PLN 157.4B | PLN 273.75 | 1.38% down | 79% up | ||
| 13 | PTC TherapeuticsPTCT · Health Care | PLN 2.8B | PLN 19.7B | PLN 235.77 | 3.16% down | 21% down | ||
| 14 | TG TherapeuticsTGTX · Health Care | PLN 1.8B | PLN 39.6B | PLN 262.27 | 1.88% down | 117% up | ||
| 15 | BioMarin PharmaceuticalBMRN · Health Care | PLN 1.4B | PLN 48.1B | PLN 248.28 | 0.02% down | 17% up | ||
| 16 | Alnylam PharmaceuticalsALNY · Health Care | PLN 1.3B | PLN 80B | PLN 597.54 | 1.06% down | 66% down | ||
| 17 | Ligand PharmaceuticalsLGND · Health Care | PLN 503.1M | PLN 23.2B | PLN 1,159.91 | 3.94% down | 50% up | ||
| 18 | Corcept TherapeuticsCORT · Health Care | PLN 402.8M | PLN 28.7B | PLN 262.67 | 4.15% down | 10% down | ||
| 19 | Amneal PharmaceuticalsAMRX · Health Care | PLN 291.3M | PLN 30.1B | PLN 86.47 | 2.24% down | 90% up | ||
| 20 | Arrowhead PharmaceuticalsARWR · Health Care | -PLN 6.6M | PLN 24.9B | PLN 176.45 | 1.25% up | 13% up | ||
| 21 | Mirum PharmaceuticalsMIRM · Health Care | -PLN 94.4M | PLN 25.2B | PLN 386.08 | 3.27% up | 34% up | ||
| 22 | Travere TherapeuticsTVTX · Health Care | -PLN 103.3M | PLN 18.7B | PLN 195.25 | 3.86% down | 45% up | ||
| 23 | VeradermicsMANE · Health Care | -PLN 282.9M | PLN 21.2B | PLN 502.83 | 0.38% down | 231% up | ||
| 24 | Belite BioBLTE · Health Care | -PLN 313.7M | PLN 24.8B | PLN 610.48 | 3.33% down | 43% up | ||
| 25 | Oruka TherapeuticsORKA · Health Care | -PLN 426.2M | PLN 26.7B | PLN 394.41 | 1.91% up | 255% up | ||
| 26 | ErascaERAS · Health Care | -PLN 503.5M | PLN 20.2B | PLN 57.48 | 3.34% up | 395% up | ||
| 27 | Protagonist TherapeuticsPTGX · Health Care | -PLN 526.1M | PLN 32.7B | PLN 501.33 | 2.47% down | 51% up | ||
| 28 | Spyre TherapeuticsSYRE · Health Care | -PLN 627.4M | PLN 37.5B | PLN 394.65 | 3.77% down | 332% up | ||
| 29 | Dianthus TherapeuticsDNTH · Health Care | -PLN 656.2M | PLN 19.3B | PLN 342.91 | 1.01% up | 108% up | ||
| 30 | Edgewise TherapeuticsEWTX · Health Care | -PLN 678.3M | PLN 18.2B | PLN 166.42 | 0.48% down | 86% up | ||
| 31 | Axsome TherapeuticsAXSM · Health Care | -PLN 740.5M | PLN 28.8B | PLN 548.47 | 1.25% up | 6% down | ||
| 32 | Definium TherapeuticsDFTX · Health Care | -PLN 743M | PLN 16.3B | PLN 119.17 | 1.24% up | 168% up | ||
| 33 | Rhythm PharmaceuticalsRYTM · Health Care | -PLN 794.5M | PLN 32.7B | PLN 472.15 | 1.88% down | 18% up | ||
| 34 | Elanco Animal HealthELAN · Health Care | -PLN 937.8M | PLN 53.1B | PLN 106.27 | 1.54% down | 26% up | ||
| 35 | Madrigal PharmaceuticalsMDGL · Health Care | -PLN 1.2B | PLN 37.3B | PLN 1,603.76 | 0.34% down | 27% down | ||
| 36 | Legend BiotechLEGN · Health Care | -PLN 1.2B | PLN 12.6B | PLN 65.08 | 0.92% down | 41% down | ||
| 37 | Praxis Precision MedicinesPRAX · Health Care | -PLN 1.2B | PLN 35.1B | PLN 1,256.77 | 1.87% up | 86% up | ||
| 38 | Cogent BiosciencesCOGT · Health Care | -PLN 1.3B | PLN 19.5B | PLN 112.13 | 0.25% down | 20% down | ||
| 39 | Ionis PharmaceuticalsIONS · Health Care | -PLN 1.5B | PLN 18.3B | PLN 110.03 | 0.62% down | 63% down | ||
| 40 | BridgeBio PharmaBBIO · Health Care | -PLN 3B | PLN 61.6B | PLN 316.03 | 0.22% up | 21% up | ||
| 41 | CytokineticsCYTK · Health Care | -PLN 3.2B | PLN 29B | PLN 208.02 | 0.27% up | 19% down | ||
| 42 | Summit TherapeuticsSMMT · Health Care | -PLN 4.4B | PLN 34.2B | PLN 42.73 | 0.67% up | 36% down | ||
| 43 | InsmedINSM · Health Care | -PLN 5.2B | PLN 128.1B | PLN 583.96 | 20.58% up | 40% down | ||
| 44 | ViatrisVTRS · Health Care | -PLN 14.2B | PLN 92.1B | PLN 80.36 | 1.97% down | 99% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0423 PLN).
Questions and answers
Which pharmaceutical companies in the United States rank first by earnings?
Johnson & Johnson (PLN 108.4B), Eli Lilly (PLN 83.4B) and Merck & Co (PLN 73.8B) are the top three of the 44 pharmaceutical companies in the United States ranked by earnings as of 20 Nov 2026, 04:38 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by earnings.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by earnings have a combined market value of PLN 15.1T as of 20 Nov 2026, 04:38 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by earnings”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.